Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Vistry CEO makes share purchase

(Sharecast News) - Vistry Group revealed on Wednesday that chief executive Greg Fitzgerald had acquired 23,172 ordinary shares in the FTSE 250-listed housebuilding firm. Fitzgerald, who took over as CEO in April 2017, purchased the shares on Monday at an average price of 1,180.50p each, for a total value of £273,545.47.

As of 1630 BST, Vistry Group shares were up 0.42% at 1,203.0p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Vistry Group (VTY) Director name: Fitzgerald,Greg Amount purchased: 23,172 @ 1,180.50p Value: £273,545.47

Hilton Food Group (HFG) Director name: Murrells,Steve Amount purchased: 10,795 @ 915.00p Value: £98,774.25

Cvc Income & Growth Limited Npv Euro (CVCE) Director name: Kirkby ,Robert Amount purchased: 26,709 @ 112.30p Value: £33,293.57

Oxford Nanopore Technologies (ONT) Director name: Priestman ,Kate Amount purchased: 23,564 @ 105.54p Value: £24,869.45

Hilton Food Group (HFG) Director name: Osborne,Matt Amount purchased: 2,292 @ 915.00p Value: £20,971.80

Naked Wines (WINE) Director name: Pailing,Jack Amount purchased: 30,000 @ 52.23p Value: £15,668.40

Maven Income & Growth 3 Vct (MIG3) Director name: Priseman ,David Amount purchased: 29,638 @ 50.61p Value: £14,999.79

Transense Technologies (TRT) Director name: Maughan,Ryan Amount purchased: 9,992 @ 100.00p Value: £9,992.00

Transense Technologies (TRT) Director name: Maughan,Ryan Amount purchased: 9,992 @ 100.00p Value: £9,992.00

Jpmorgan Us Smaller Co. Inv Tst (JUSC) Director name: Neary,Dominic Amount purchased: 2,000 @ 395.47p Value: £7,909.38

Transense Technologies (TRT) Director name: Rogers,Nigel Amount purchased: 5,950 @ 101.90p Value: £6,063.05

Transense Technologies (TRT) Director name: Parker ,Stephen Amount purchased: 4,921 @ 101.50p Value: £4,994.81

Transense Technologies (TRT) Director name: Segal,Melvyn Amount purchased: 4,890 @ 102.00p Value: £4,987.80

Transense Technologies (TRT) Director name: Maughan,Ryan Amount purchased: 3,563 @ 98.00p Value: £3,491.74

Transense Technologies (TRT) Director name: Rogers,Nigel Amount purchased: 2,550 @ 101.90p Value: £2,598.45

Top Director Sells

Dg Innovate (DGI) Director name: Boughtwood,Martin Hugh Amount sold: 101,068,952 @ 0.15p Value: £149,986.33

Centamin (di) (CEY) Director name: Horgan,Martin Amount sold: 95,783 @ 122.53p Value: £117,362.91

Share this article

Related Sharecast Articles

Director dealings: British American Tobacco's Karen Guerra purchases shares
(Sharecast News) - British American Tobacco revealed on Thursday that non-executive director Karen Guerra had acquired 6,000 ordinary shares in the FTSE 100-listed tobacco giant.
Director dealings: Convatec non-executive director makes share purchase
(Sharecast News) - Convatec revealed on Wednesday that non-executive director Jens Viebke had acquired 24,400 ordinary shares in the FTSE 100-listed medical products and technology firm.
Director dealings: Mortgage Advice Bureau chairman snaps up shares
(Sharecast News) - Mortgage Advice Bureau revealed on Tuesday that non-executive chairman Michael Jones had acquired 5,833 ordinary shares in the AIM-listed property finance platform operator.
Director dealings: Insig Ai CEO raises stake
(Sharecast News) - Insig Ai revealed on Monday at chief executive Richard Bernstein had acquired 400,000 ordinary shares in the AIM-listed data infrastructure and machine learning firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.